B

M

BRICKMAN , Marla

Last name: BRICKMAN

First name: Marla

May 2010 (v1)

Journal article

Metadata-only

Phase III randomized trial of sunitinib versus capecitabine in patients with previously treated HER2-negative advanced breast cancer.

Barrios, Carlos Liu, Mei-Ching Lee, Soo Chin

This multicenter, randomized, open-label phase III trial (planned enrollment: 700 patients) was conducted to test the hypothesis that single-agent sunitinib improves progression-free survival (PFS) compared with capecitabine as treatment for advanced breast cancer (ABC). Patients with HER2-negative ABC that recurred after anthracycline and...

Uploaded on: December 3, 2022